Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-08-09
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 30
- Registration Number
- NCT00187707
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
Genetic Basis for Variation in the Renal Elimination of Metformin
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 23
- Registration Number
- NCT00187720
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20
- Registration Number
- NCT00187681
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francsico, California, United States
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Recruiting
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 2500
- Registration Number
- NCT00187512
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
A Case Management Intervention to Prevent ER Visits in HIV-infected Persons
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 612
- Registration Number
- NCT00187590
- Locations
- ๐บ๐ธ
University Medical Center, Fresno, California, United States
Child-Parent Psychotherapy for Preschooler Witnesses of Domestic Violence Program
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 60
- Registration Number
- NCT00187772
- Locations
- ๐บ๐ธ
Child Trauma Research Project, San Francisco, California, United States
Phosphate Intake's Effect on the Skeletal System - Pilot
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-10-09
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 27
- Registration Number
- NCT00187629
- Locations
- ๐บ๐ธ
University of California, San Francisco, California, United States
Effect of, OAT3, on the Renal Secretion of Cefotaxime
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 24
- Registration Number
- NCT00187655
Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-02-10
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 25
- Registration Number
- NCT00187551
- Locations
- ๐บ๐ธ
San Francisco General Hospital, San Francisco, California, United States
Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2008-06-04
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 100
- Registration Number
- NCT00187447
- Locations
- ๐บ๐ธ
University of Chicago, Chicago, Illinois, United States
๐บ๐ธUniversity of California San Francisco, Davis, California, United States
๐บ๐ธBrown University, Providence, Rhode Island, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath